Explore Our Nephrology Preclinical Research Brochure
This brochure introduces Ace Therapeutics' comprehensive nephrology research capabilities, highlighting our integrated solutions for kidney disease modeling, preclinical pharmacology, and translatform drug development. It provides an overview of our disease expertise, experimental models, technology platforms, and end-to-end research services designed to support every stage of kidney disease drug discovery.
What You'll Find Inside
Comprehensive Kidney Disease Coverage
- Therapeutic areas spanning acute and chronic kidney diseases
- Diabetic kidney disease, polycystic kidney disease, glomerulonephritis, kidney stones, and genetic kidney disorders
- Disease-specific research strategies and applications
Diverse In Vitro and In Vivo Disease Models
- Renal cell cultures, kidney organoids, and kidney-on-a-chip models
- Well-established animal models for AKI, CKD, DKD, PKD, FSGS, and immune-mediated nephropathies
- Model selection guidance for different research objectives
End-to-End Preclinical Research Services
- Target identification and functional validation
- In vitro compound screening and efficacy assessment
- In vivo proof-of-concept studies
- ADME/DMPK, safety assessment, and nephrotoxicity evaluation
Advanced Technology Platforms
- Physiological and renal functional assays
- Histology and pathology analysis
- Molecular biology and biomarker analysis
- Multimodal imaging technologies for renal research
Experimental Workflows and Readouts
- Standardized workflows for in vitro and in vivo studies
- Comprehensive functional, molecular, biochemical, and histopathological endpoints
- Key efficacy, mechanism, and safety evaluation parameters
Download the brochure to discover how Ace Therapeutics' integrated nephrology research platform can support your kidney disease research and accelerate the development of novel renal therapeutics.